Skirball Institute of Biomolecular Medicine and Department of Microbiology, New York University School of Medicine, New York, New York 10016
Received 29 April 2005/ Returned for modification 31 May 2005/ Accepted 8 August 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
22 nucleotides (nt) in length that function in gene regulation (22, 24, 45). In animal cells, miRNAs repress translation by annealing to mRNAs to which they are imperfectly complementary. Only a few mRNAs that are regulated by miRNAs in animals have been identified definitively, and little is known about the molecular mechanism by which they are repressed.
In animals, miRNAs are generated by processing of long primary transcripts (pri-miRNAs) by two RNase III-like endonucleases, Drosha and Dicer (8, 12, 18, 25). pri-miRNA cleavage by Drosha releases a 60- to 70-nt stem-loop intermediate (pre-miRNA) that is subsequently cut by Dicer to generate an RNA duplex comprising the miRNA and a complementary strand. The miRNA is then assembled as a single strand into a ribonucleoprotein complex and delivered to its mRNA targets. These miRNPs appear to be related, at least in part, to the ribonucleolytic complexes responsible for RNA interference, which contain
22-nt silencing RNAs (siRNAs) that guide mRNA cleavage at sites to which they are perfectly complementary (7, 10, 33, 37, 55). The similarities between translational repression by partially complementary miRNAs and nucleolytic silencing by fully complementary siRNAs have led to the proposal that they may represent divergent branches of a unified pathway for genetic control (11).
Gene regulation by naturally occurring miRNAs was first observed in Caenorhabditis elegans, where the miRNA products of the lin-4 and let-7 genes were shown to repress heterochronic genes involved in development (9, 24, 35, 44, 52). For example, lin-4 controls the expression of the lin-14, lin-28, and hbl-1 genes of C. elegans, targeting the mRNA transcripts of these genes for downregulation by pairing with imperfectly complementary sites in the 3' untranslated region (UTR) and inhibiting translation (31, 40, 47, 52). By repressing these genes at specific times during larval development, lin-4 ensures the proper timing of cell fate transitions important for morphogenesis. In the case of the C. elegans lin-28 gene, which encodes a putative RNA-binding protein, expression is high in the first larval stage and then declines markedly in response to lin-4 and a second regulatory circuit that is lin-4 independent (35, 47). Gain-of-function mutations in lin-28 that abolish lin-4 repression cause a retarded developmental phenotype in various cell lineages, whereas loss-of-function mutations result in precocious development (1, 35).
Much less is known about the function of miRNAs in higher organisms, such as vertebrates, where the low degree of complementarity between miRNAs and their mRNA targets and an incomplete understanding of the rules governing miRNA function have complicated the identification of genes regulated in this manner. Indeed, despite the presence of hundreds of different miRNAs in vertebrate cells (2, 22, 29, 37, 42) and sequence-based predictions of possible regulatory targets (14, 19, 27, 28, 50), few such targets of vertebrate miRNA regulation have yet been verified empirically (15, 20, 28, 38, 39, 43, 54, 57), and for fewer still has a natural change in miRNA abundance been shown to modulate gene expression by directly targeting a specific mRNA in response to a regulatory signal.
Here we report the identification of the mammalian lin-28 gene as a regulatory target of miR-125b, a mammalian micro-RNA homologous to lin-4. Within the 3' UTR of human and mouse lin-28 are two conserved miRNA-responsive elements (miREs) that are principally responsible for mediating the repressive effect of miR-125b and its paralog miR-125a. In mouse P19 embryonal carcinoma cells induced to differentiate into neurons, a marked increase in miR-125b abundance helps to downregulate lin-28 gene expression. Interestingly, the mechanism by which miR-125b represses lin-28 in mammalian cells appears to involve reductions not only in translational efficiency but also in mRNA abundance.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1, pCL-L28
2, pCL-L28
0, pCL-L28
1+2, pCL-L28
0+1+2, pCL-L28
L7. and pCL-L28
0+1+2+L7 were derived from plasmid pCL-L28 by deleting a 15-bp segment encoding miRE1 (CACTGTGTTCTCAGG), an 18-bp segment encoding miRE2 (CATGAGCAATCTCAGGGA), a 13-bp segment encoding miRE0 (CATGTATCTCAGG), and/or a 27-bp segment encoding L7 (GAGTGCACAGCCTATTGAACTACCTCA). In other derivatives of pCL-L28, lin-28 3' UTR segments with imperfect complementarity to miR-9 (TTTACTGCTAAAAACCAAAG), miR-30 (TCCGTGTTCTTTGGGGGTTTTGTTTACA), or miR-128 (GAGATCACCGCAAACCTACCTTACTGTG) were deleted. Plasmid pCL was constructed from pCMV-Luc by inserting a 0.11-kb spacer derived from the human immunodeficiency virus type 1 env gene between the luciferase stop codon and an XbaI site located just downstream of it. Plasmids pCL-2E1, pCL-4E1, and pCL-6E1 were constructed by inserting two, four, or six tandem copies of human lin-28 miRE1 (TCCTGCACTGTGTTCTCAGGTACAT) into the XbaI site of pCL. Plasmids pCL-2E2, pCL-4E2, pCL-6E2, pCL-2E0, pCL-4X, pCL-6X, and pCL-2Y were constructed similarly, except that multiple copies of miRE2 (AGGTACATGAGCAATCTCAGGGATAGCC), miRE0 (ACTGCCATGTATCTCAGGCTTGG), element X (CCAAATGCAAGTGAGGGTTCTGGGGGCAACC), or element Y (TTCTGTGGAAGGAGATCTCTCAGGAGTAA) were inserted into pCL. Plasmids pCL-BGH-con, pCL-BGHmut-con, pCL-BGH-6E1, and pCL-BGHmut-6E1 were constructed by inserting a 0.23-kb pcDNA3 gene fragment (Invitrogen) containing a wild-type (AATAAA) or mutated (TTCTTT) bovine growth hormone polyadenylation signal into pCL-con or pCL-6E1 at an EcoRI site located 10 bp downstream of the luciferase coding region. Plasmid pCL-6E1+hp was derived from pCL-6E1 by inserting the sequence CGGGGCGCGTGGTGGCGGCTGCAGCCGCCACCACGCGCCCCGGACGCGTAGCT at a HindIII site 30 bp upstream of the luciferase initiation codon. Plasmid pBC21/CMV/ß-Gal (56), which encodes ß-galactosidase, was used as an internal standard.
Plasmid pMIR125a, which was used to transfect 293T cells, was constructed from pCMV-Luc by replacing the luciferase translational unit between the CMV promoter and the SV40 3' UTR with a 1.13-kb fragment of human chromosome 19 that encodes miR-125a flanked upstream by 166 nt and downstream by 941 nt. In plasmid pMIR125a
, a 58-bp segment of pMIR125a that encodes most of the pre-miR-125a stem-loop was deleted. Plasmid pMIR125b, also used to transfect 293T cells, was constructed from pCMV-Luc by replacing the luciferase translational unit with a 0.77-kb fragment of human chromosome 21 that encodes miR-125b flanked upstream by 484 nt and downstream by 270 nt. In plasmid pMIR125b
, a 59-bp segment of pMIR125b that encodes most of the pre-miR-125b stem-loop was deleted. Plasmid pMIR125b-U1A was derived from pMIR125b by introducing a T
A substitution at the position corresponding to the 5'-terminal nucleotide of miR-125b. Plasmid pSH-MIR125b, which was used to transfect P19 cells, was constructed by inserting a 0.08-kb gene fragment encoding pre-miR-125b downstream of the U6 promoter of pSHAG-1 (41). For use as a negative control, plasmid pCMV-con, which encodes no miRNA-related transcript whatsoever, was constructed from pCMV-Luc by deleting the luciferase translational unit.
The synthetic siDCR RNA duplex used to knock down Dicer synthesis was prepared by annealing complementary oligonucleotides that had been chemically synthesized (5' AAAGGACCCAUUGGUGAGGAA 3' and 5' CCUCACCAAUGGGUCCUUUCU 3'; Dharmacon). The siGL2 RNA duplex used as a negative control comprised two complementary strands having the sequence 5' CGUACGCGGAAUACUUCGAdTdT 3' and 5' UCGAAGUAUUCCGCGUACGdTdT 3' (Dharmacon). The 2'-O-methyl oligonucleotide used to inhibit miR-125b function in transfected in P19 cells (UCACAAGUUAGGGUCUCAGGGA; Integrated DNA Technologies) and the nonspecific 2'-O-methyl oligonucleotide used as a negative control (AAGCGAAGCAGUGCGUCAAGUA) were purified by polyacrylamide gel electrophoresis before transfection.
Cell culture and transfection. 293T human embryonic kidney cells were grown in Dulbecco's modified Eagle's medium (GIBCO) supplemented with 10% fetal bovine serum. Transient transfection of 293T cells with DNA was performed for 12 h using GeneJuice (Novagen), following the manufacturer's protocol except that 1.5 ml of culture medium was used per 35-mm well. Transfected DNA mixtures (1 µg) contained a plasmid encoding a pri-miRNA (965 ng), a reporter plasmid (25 ng), and a plasmid encoding ß-galactosidase (10 ng).
P19 mouse embryonal carcinoma cells were cultured and induced to differentiate into neurons essentially as described previously (16). In brief, undifferentiated P19 cells were grown in
-minimal essential medium (
-MEM) (GIBCO) supplemented with 10% fetal bovine serum. Differentiation of P19 cells was induced by treatment with retinoic acid (1 µM) for 4 days in 10-cm bacteriological petri dishes, which were coated with 0.2% agarose to prevent the cells from adhering. The cells were then disaggregated by treatment with trypsin, replated on poly-D-lysine-coated tissue culture dishes, and cultured in either
-MEM medium containing 10% fetal bovine serum or, in one instance, Neurobasal medium (GIBCO) containing B27 supplement (GIBCO) and glutamine (0.5 mM).
Transient transfection of undifferentiated P19 cells with DNA, siRNA, and/or 2'-O-methyl RNA was performed overnight by using Lipofectamine 2000 (3 to 5 µl; Invitrogen; see manufacturer's protocol) in tissue culture dishes with 12 23-mm wells. Transient transfection of differentiated P19 cells was carried out overnight using cells that had been treated with retinoic acid for 4 days. The cells were trypsinized, cultured for 24 h in tissue culture dishes with 12 23-mm wells, and transfected with DNA in the presence of Lipofectamine 2000 (2 to 3 µl). The transfection medium was replaced with fresh culture medium after 6 h, and cell extracts were prepared 30 h later.
Reporter assays. Reporter lysis buffer (Promega) was used to prepare cell lysates for reporter expression assays. Luciferase activity was measured in a Tecan SpectraFluor Plus instrument by using the Bright-Glo luciferase assay system (Promega) according to the manufacturer's instructions. ß-Galactosidase activity was assayed with o-nitrophenylgalactoside by spectrophotometry, as previously described (46), or with the Galacto-Light Plus chemiluminescent reporter assay system (Applied Biosystems). Each measurement of the ratio of luciferase to ß-galactosidase activity was determined with lysates derived from at least three to four independent transfections that usually were performed on more than one day.
RNA assays. For analysis of miRNA, total cellular RNA was extracted by using Trizol reagent (Invitrogen), according to the manufacturer's instructions. Equal amounts of total RNA (10 µg) were denatured, fractionated by electrophoresis on a 15% polyacrylamide-8 M urea gel, and electroblotted and cross-linked onto a Hybond-XL nylon membrane (Amersham). The blots were probed at 38°C in PerfectHyb Plus hybridization buffer (Sigma) with terminally radiolabeled DNA oligonucleotides complementary to miR-125a or miR-125b and then washed with 0.5x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% sodium dodecyl sulfate (SDS) buffer at 38°C.
For luciferase, ß-galactosidase, and lin-28 mRNA analysis, cytoplasmic RNA was purified from cells 36 h after transfection, as previously described (49), except that Trizol reagent (Invitrogen) was used to isolate RNA from cytoplasmic extracts. Equal amounts of cytoplasmic RNA (10 µg) were denatured by glyoxal treatment (46), fractionated by electrophoresis on a 1% agarose gel, and blotted and cross-linked onto a Hybond-XL nylon membrane (Amersham). The blots were probed at 68°C in PerfectHyb Plus hybridization buffer (Sigma) with radiolabeled luciferase DNA, ß-galactosidase DNA, or lin-28 DNA prepared by random primer labeling using a High Prime DNA labeling kit (Roche) and then washed with 0.5x SSC-0.1% SDS buffer at 68°C.
Immunoblot assays. Cells were harvested and lysed with RIPA lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) containing Complete protease inhibitor (Roche). Equal amounts of each lysate were separated by electrophoresis on a 6% polyacrylamide-SDS gel and electroblotted onto a Hybond ECL nitrocellulose membrane (Amersham). Each blot was blocked with 5% dry milk in phosphate-buffered saline containing 0.05% Tween 20, probed at 4°C overnight with antibodies against human Lin-28 (polyclonal rabbit antiserum, diluted 1:1,500) or actin (1:3000, Sigma), incubated with a secondary antibody conjugated to horseradish peroxidase (1:20,000; Bio-Rad), and developed with an Immun-Star HRP chemiluminescence kit (Bio-Rad).
| RESULTS |
|---|
|
|
|---|
|
|
|
Mutational analysis of miR-125-responsive elements. That miRE1 is fairly effective at mediating the inhibitory effect of these miRNAs was somewhat surprising in view of previous reports that base pairing of the 5'-terminal segment of miRNAs with their target elements, especially miRNA nucleotides 2 to 8, is very important for repression, as is the overall free energy of duplex formation (3, 6, 20, 28). miRE1 can form consecutive Watson-Crick base pairs only with nucleotides 3 to 9 of miR-125a or miR-125b, unlike miRE2, which can base pair with nucleotides 1 to 9 (Fig. 2A). Furthermore, the duplex structures formed by miRE1 are expected to be of lower thermodynamic stability than those formed by miRE2. To investigate the basis for the efficacy of miRE1, we modified the 3' portion of this element to alter its base-pairing potential with the 5' segment of miR-125 and then tested the effect of these mutations on repression of a luciferase reporter containing two such elements (Fig. 4).
|
U substitution at position 1 (M3) was deleterious. Among the miRE1 variants that could form seven consecutive base pairs with the 5' segment of miR-125b, pairing with nucleotides 2 to 8 (M4) or 3 to 9 (M1) was more effective than pairing with nucleotides 1 to 7 (M5). Additional experiments showed that the contribution of the 3'-terminal adenosine residue to miRE1 function is not a consequence of its complementarity to the uridine at position 1 of miR-125b. This was determined by changing the first nucleotide of miR-125b from U to A (miR-125b-U1A) and measuring the efficacy of the modified miRNA in downregulating the same set of reporters, each of which contains a pair of miREs that end with either an adenosine or a uridine residue. To within experimental error, the mutant and wild-type forms of miR-125b were indistinguishable in their ability to repress every sequence variant of miRE1, regardless of the base-pairing potential of the 3'-terminal miRE residue (Fig. 4B). That an adenosine at this position can enhance miRE1 function irrespective of its ability to base pair may also help to explain the lesser activity of miRE0 and the inactivity of element Y, both of which can pair with nucleotides 3 to 9 of miR-125b but lack a terminal adenosine residue opposite nucleotide 1 (Fig. 3).
Influence of miR-125 on mRNA abundance. Gene regulation by miRNAs that are imperfectly complementary to their mRNA targets is generally thought to be achieved via a translational repression mechanism (5, 38, 40, 52, 56), whereas silencing by perfectly complementary siRNAs typically involves accelerated mRNA degradation (33, 51). To determine whether repression mediated by miRE1 and miRE2 occurs only at the level of translation, the cytoplasmic concentration of luciferase reporter mRNAs bearing six copies of miRE1 or miRE2 was compared in the presence or absence of miR-125a or miR-125b. The significant decline in luciferase protein synthesis observed in cells that produced either of these miRNAs was accompanied by a smaller but significant decrease in the concentration of the luciferase reporter mRNA (Fig. 5). In each case (and in the case of a reporter containing the entire lin-28 3' UTR; data not shown), the calculated reductions in mRNA abundance and translational efficiency (protein yield per mRNA molecule) were approximately equal in magnitude. No such change in either mRNA or protein concentration was observed for a luciferase control gene that lacked the lin-28 miREs but was expressed under the control of the same promoter.
|
|
|
|
That miR-125b in particular likely contributes to lin-28 repression during differentiation of P19 cells was implied by experiments showing that this miRNA is able to downregulate expression of the endogenous lin-28 gene in undifferentiated P19 cells engineered to produce miR-125b at a physiological concentration. Uninduced P19 cells were transfected with a plasmid encoding pre-miR-125b so as to raise the cellular abundance of the corresponding miRNA to a level comparable to that in retinoic acid-treated cells (Fig. 9) and in rat hippocampal neurons 3 days before birth (data not shown). The increased concentration of miR-125b in these cells resulted in a marked reduction in Lin-28 protein synthesis compared to that in P19 cells transfected with a control plasmid that did not encode the miRNA (Fig. 9). This reduction in protein synthesis was accompanied by a significant decrease in the cytoplasmic concentration of lin-28 mRNA, as observed in 293T cells for reporter mRNAs bearing the lin-28 miREs but transcribed under the control of a different promoter. These findings indicate that even in the absence of differentiation, miR-125b is alone sufficient to cause significant repression of lin-28 gene expression in P19 cells, a conclusion consistent with a similar role for this miRNA in differentiating P19 cells.
|
|
|
40% relative to that of a reporter with an intact 3' UTR (Fig. 11A). The regulatory effects of this element and the miR-125-responsive elements within the lin-28 3' UTR were additive. We conclude that let-7 makes a smaller, but significant, contribution to lin-28 repression in differentiating P19 cells. | DISCUSSION |
|---|
|
|
|---|
The efficacy of miRE1 and miRE2 as regulatory targets of miR-125b and its homolog miR-125a is not merely a consequence of their potential for stable base pairing with these miRNAs. These two lin-28 elements are similarly potent in mediating repression despite significant differences in the length and thermodynamic stability of the duplex that each can form with the 5' segment of miR-125a and miR-125b, the miRNA segment believed to be most important for determining miRE activity (6, 19, 20, 28). Whereas miRE2 can base pair with the first nine nucleotides of miR-125, a property consistent with previous reports as to the importance of base pairing to miRNA nucleotides 2 to 8, miRE1 can form consecutive Watson-Crick base pairs only with nucleotides 3 to 9. Our data indicate that the presence in miRE1 of an adenosine opposite the 5'-terminal nucleotide of miR-125 (nucleotide 1) enables this element to function well regardless of the base-pairing potential of this adenosine residue and despite the inability of the adjacent miRE residue to pair with the second nucleotide of miR-125. By extrapolation, this finding offers an explanation for the preponderance of adenosines at this position in predicted vertebrate miREs irrespective of the identity of the 5'-terminal miRNA nucleotide (27), and it suggests that the protein complex surrounding the miRE-miRNA duplex may have a surface for binding this adenosine nucleotide. These results may also help to explain why two other lin-28 elements that can form thermodynamically favorable duplexes with miR-125 (miRE0 and element Y) do not function well as miREs, since neither has a 3'-terminal adenosine or is capable of base pairing with the second nucleotide of miR-125. On the other hand, the inactivity of element X as an miR125a/b target is likely due to the multiple G-U base pairs that it would form with the 5' portion of these two miRNAs, since wobble pairs in this crucial region are thought to be detrimental to miRNA function (6).
Initial studies with mammalian cells of genetic repression mediated by artificial or natural miREs partially complementary to an miRNA found that diminished reporter protein synthesis was not accompanied by a significant reduction in mRNA abundance (5, 38, 56). These and similar results from earlier studies of miRNA function in C. elegans (40, 47, 52) led to the conclusion that unlike the degradative repression mechanism of siRNAs (and at least one mammalian miRNA [54]) that are perfectly complementary to their mRNA targets, repression by imperfectly complementary miRNAs might occur exclusively at the level of translation. However, we have discovered that miR-125b causes not only a reduction in Lin-28 protein levels but also a substantial decrease in lin-28 mRNA abundance that is dependent on the presence of the miREs within the message but independent of both the mRNA context of the miREs and the promoter that controls mRNA synthesis. We have also found that in mammalian cells, let-7 causes a similar reduction in the concentration of a reporter mRNA containing multiple copies of the lin-28 L7 element (data not shown). These results suggest that the means by which miR-125b and let-7 repress lin-28 expression in mammals involves both impaired translation and a posttranscriptional mechanism for reducing the mRNA concentration, possibly via accelerated mRNA degradation. Consistent with these observations is a recent report that transfection of human cells with miR-1 or miR-124 can diminish the abundance of certain mRNAs (30), although those experiments did not establish whether the effect was posttranscriptional or whether the mRNA elements responsible for repressing gene expression were also necessary and sufficient to cause a concomitant change in mRNA concentration. Furthermore, our data indicate that the reduction in mRNA abundance mediated by miR-125b is not a secondary consequence of its inhibitory effect on translation. Whatever the mechanism may be, these findings indicate that the regulatory processes used by miRNAs to repress mRNAs to which they are imperfectly complementary or by siRNAs to silence messages with perfect complementarity may in some instances be less distinct than originally thought.
| ACKNOWLEDGMENTS |
|---|
These studies were supported by a research grant to J.G.B. from the National Institutes of Health (GM55624).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Berezikov, E., V. Guryev, J. van de Belt, E. Wienholds, R. H. Plasterk, and E. Cuppen. 2005. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120:21-24.[CrossRef][Medline]
3. Brennecke, J., A. Stark, R. B. Russell, and S. M. Cohen. 2005. Principles of microRNA-target recognition. PloS. Biology 3:e85.[CrossRef][Medline]
4. Brewer, G. J., J. R. Torricelli, E. K. Evege, and P. J. Price. 1993. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:567-576.[CrossRef][Medline]
5. Doench, J. G., C. P. Petersen, and P. A. Sharp. 2003. siRNAs can function as miRNAs. Genes Dev. 17:438-442.
6. Doench, J. G., and P. A. Sharp. 2004. Specificity of microRNA target selection in translational repression. Genes Dev. 18:504-511.
7. Elbashir, S. M., W. Lendeckel, and T. Tuschl. 2001. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:188-200.
8. Grishok, A., A. E. Pasquinelli, D. Conte, N. Li, S. Parrish, I. Ha, D. L. Baillie, A. Fire, G. Ruvkun, and C. C. Mello. 2001. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106:23-34.[CrossRef][Medline]
9. Ha, I., B. Wightman, and G. Ruvkun. 1996. A bulged lin-4/lin-14 RNA duplex is sufficient for Caenorhabditis elegans lin-14 temporal gradient formation. Genes Dev. 10:3041-3050.
10. Hammond, S. M., S. Boettcher, A. A. Caudy, R. Kobayashi, and G. J. Hannon. 2001. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293:1146-1150.
11. Hannon, G. J. 2002. RNA interference. Nature 418:244-251.[CrossRef][Medline]
12. Hutvagner, G., J. McLachlan, A. E. Pasquinelli, E. Balint, T. Tuschl, and P. D. Zamore. 2001. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293:834-838.
13. Hutvagner, G., M. J. Simard, C. C. Mello, and P. D. Zamore. 2004. Sequence-specific inhibition of small RNA function. PloS Biol. 2:e98.
14. John, B., A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks. 2004. Human MicroRNA targets. PloS Biol. 2:e363.[CrossRef][Medline]
15. Johnson, S. M., H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K. L. Reinert, D. Brown, and F. J. Slack. 2005. RAS is regulated by the let-7 microRNA family. Cell 120:635-647.[CrossRef][Medline]
16. Jones-Villeneuve, E. M., M. W. McBurney, K. A. Rogers, and V. I. Kalnins. 1982. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell Biol. 94:253-262.
17. Kawasaki, H., and K. Taira. 2004. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 431:211-217.[CrossRef][Medline]
18. Ketting, R. F., S. E. Fischer, E. Bernstein, T. Sijen, G. J. Hannon, and R. H. Plasterk. 2001. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15:2654-2659.
19. Kiriakidou, M., P. T. Nelson, A. Kouranov, P. Fitziev, C. Bouyioukos, Z. Mourelatos, and A. Hatzigeorgiou. 2004. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 18:1165-1178.
20. Kloosterman, W. P., E. Wienholds, R. F. Ketting, and R. H. Plasterk. 2004. Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res. 32:6284-6291.
21. Krichevsky, A. M., K. S. King, C. P. Donahue, K. Khrapko, and K. S. Kosik. 2003. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274-1281.
22. Lagos-Quintana, M., R. Rauhut, W. Lendeckel, and T. Tuschl. 2001. Identification of novel genes coding for small expressed RNAs. Science 294:853-858.
23. Lagos-Quintana, M., R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735-739.[CrossRef][Medline]
24. Lee, R. C., R. L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.[CrossRef][Medline]
25. Lee, Y., C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, P. Provost, O. Radmark, S. Kim, and V. N. Kim. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415-419.[CrossRef][Medline]
26. Lee, Y. S., H. K. Kim, S. Chung, K. S. Kim, and A. Dutta. 2005. Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J. Biol. Chem. 280:16635-16641.
27. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.[CrossRef][Medline]
28. Lewis, B. P., I. H. Shih, M. W. Jones-Rhoades, D. P. Bartel, and C. B. Burge. 2003. Prediction of mammalian microRNA targets. Cell 115:787-798.[CrossRef][Medline]
29. Lim, L. P., M. E. Glasner, S. Yekta, C. B. Burge, and D. P. Bartel. 2003. Vertebrate microRNA genes. Science 299:1540.
30. Lim, L. P., N. C. Lau, P. Garrett-Engele, A. Grimson, J. M. Schelter, J. Castle, D. P. Bartel, P. S. Linsley, and J. M. Johnson. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773.[CrossRef][Medline]
31. Lin, S. Y., S. M. Johnson, M. Abraham, M. C. Vella, A. Pasquinelli, C. Gamberi, E. Gottlieb, and F. J. Slack. 2003. The C. elegans hunchback Homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev. Cell 4:639-650.[CrossRef][Medline]
32. Meister, G., M. Landthaler, Y. Dorsett, and T. Tuschl. 2004. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10:544-550.
33. Montgomery, M. K., S. Xu, and A. Fire. 1998. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 95:15502-15507.
34. Morris, K. V., S. W. Chan, S. E. Jacobsen, and D. J. Looney. 2004. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305:1289-1292.
35. Moss, E. G., R. C. Lee, and V. Ambros. 1997. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88:637-646.[CrossRef][Medline]
36. Moss, E. G., and L. Tang. 2003. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev. Biol. 258:432-442.[CrossRef][Medline]
37. Mourelatos, Z., J. Dostie, S. Paushkin, A. Sharma, B. Charroux, L. Abel, J. Rappsilber, M. Mann, and G. Dreyfuss. 2002. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16:720-728.
38. Nelson, P. T., A. G. Hatzigeorgiou, and Z. Mourelatos. 2004. miRNP:mRNA association in polyribosomes in a human neuronal cell line. RNA 10:387-394.
39. O'Donnell, K. A., E. A. Wentzel, K. I. Zeller, C. V. Dang, and J. T. Mendell. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843.[CrossRef][Medline]
40. Olsen, P. H., and V. Ambros. 1999. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 216:671-680.[CrossRef][Medline]
41. Paddison, P. J., A. A. Caudy, E. Bernstein, G. J. Hannon, and D. S. Conklin. 2002. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16:948-958.
42. Pasquinelli, A. E., B. J. Reinhart, F. Slack, M. Q. Martindale, M. I. Kuroda, B. Maller, D. C. Hayward, E. E. Ball, B. Degnan, P. Muller, J. Spring, A. Srinivasan, M. Fishman, J. Finnerty, J. Corbo, M. Levine, P. Leahy, E. Davidson, and G. Ruvkun. 2000. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86-89.[CrossRef][Medline]
43. Poy, M. N., L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, P. E. Macdonald, S. Pfeffer, T. Tuschl, N. Rajewsky, P. Rorsman, and M. Stoffel. 2004. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226-230.[CrossRef][Medline]
44. Reinhart, B. J., F. J. Slack, M. Basson, A. E. Pasquinelli, J. C. Bettinger, A. E. Rougvie, H. R. Horvitz, and G. Ruvkun. 2000. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906.[CrossRef][Medline]
45. Reinhart, B. J., E. G. Weinstein, M. W. Rhoades, B. Bartel, and D. P. Bartel. 2002. MicroRNAs in plants. Genes Dev. 16:1616-1626.
46. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
47. Seggerson, K., L. Tang, and E. G. Moss. 2002. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev. Biol. 243:215-225.[CrossRef][Medline]
48. Sempere, L. F., S. Freemantle, I. Pitha-Rowe, E. Moss, E. Dmitrovsky, and V. Ambros. 2004. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5:R13.[CrossRef][Medline]
49. Shyu, A.-B., M. E. Greenberg, and J. G. Belasco. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:60-72.
50. Smalheiser, N. R., and V. I. Torvik. 2004. A population-based statistical approach identifies parameters characteristic of human microRNA-mRNA interactions. BMC Bioinformatics 5:139.[CrossRef][Medline]
51. Tuschl, T., P. D. Zamore, R. Lehmann, D. P. Bartel, and P. A. Sharp. 1999. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13:3191-3197.
52. Wightman, B., I. Ha, and G. Ruvkun. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75:855-862.[CrossRef][Medline]
53. Yang, D. H., and E. G. Moss. 2003. Temporally regulated expression of Lin-28 in diverse tissues of the developing mouse. Gene Expr. Patterns 3:719-726.[CrossRef][Medline]
54. Yekta, S., I. H. Shih, and D. P. Bartel. 2004. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304:594-596.
55. Zamore, P. D., T. Tuschl, P. A. Sharp, and D. P. Bartel. 2000. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25-33.[CrossRef][Medline]
56. Zeng, Y., E. J. Wagner, and B. R. Cullen. 2002. Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9:1327-1333.[CrossRef][Medline]
57. Zhao, Y., E. Samal, and D. Srivastava. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-220.[CrossRef][Medline]
This article has been cited by other articles: